Clinical presentation and treatment of Wilson's disease: A single-centre experience

European Neurology

Volumn 50, Issue 1, 2003, Pages 48-52

  Pellecchia, M T ^a   Criscuolo, C ^a   Longo, K ^a   Campanella, G ^a   Filla, A ^a   Barone, P ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Clinical presentation; Penicillamine; Wilson's disease; Zinc sulphate

Indexed keywords

PENICILLAMINE; ZINC SULFATE;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; BODY POSTURE; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG SCREENING; DRUG TOLERANCE; DYSARTHRIA; DYSTONIA; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; LIVER DISEASE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; ONSET AGE; OUTPATIENT DEPARTMENT; PREDICTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SYMPTOMATOLOGY; TERATOGENICITY; TREATMENT OUTCOME; WILSON DISEASE;

ADOLESCENT; ADULT; BRAIN; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; DYSARTHRIA; DYSTONIA; FEMALE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; LONG-TERM CARE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; NEUROLOGIC EXAMINATION; PENICILLIC ACID; PREGNANCY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; ZINC SULFATE;

EID: 0037970122     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070858     Document Type: Article

References (19)

1. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW: The Wilson's disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-337.
2. Scheinberg I, Sternleib I: Wilson's disease; in Smith LH (ed): Major Problems in Internal Medicine. Philadelphia, WB Saunders, 1984, pp 126-155.
3. Walshe JM: Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956;21:487-495.
4. Brewer GJ: Practical recommendations and new therapies for Wilson's disease. Drugs 1995;50:240-249.
5. Denny Brown D: Hepatolenticular degeneration (Wilson's disease). Two different components. N Engl J Med 1964;270:1149-1156.
6. Brewer GJ: The treatment of Wilson's disease. Adv Exp Med Biol 1999;448:115-126.
7. Brewer GJ: Penicillamine should not be used as initial therapy in Wilson's disease. Mov Disord 1999;14:551-554.
8. Walshe JM: Penicillamine: The treatment of first choice for patients with Wilson's disease. Mov Disord 1999;14:545-550.
9. Walshe JM, Yealland M: Chelation treatment of neurological Wilson's disease. Q J Med 1993;86:197-204.
10. Brewer GJ, Yuzbasiyan-Gurkan V: Wilson's disease. Medicine 1992;71:139-164.
11. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G: Wilson disease: Clinical presentation, treatment and survival. Ann Int Med 1991;115:720-726.
12. Mjolnerod OK, Dommerud SA, Rasmussen K, Gjeruldsen ST: Congenital connective tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet 1971;1:673-675.
13. Solomon L, Abrams G, Dinner M, Berman L: Neonatal abnormalities associated with D-penicillamine treatment during pregnancy. N Engl J Med 1977;296:54-55.
14. Walshe JM: Pregnancy in Wilson's disease. Q J Med 1977;46:73-83.
15. Scheinberg IH, Sternlieb I: Pregnancy in penicillamine-treated patients with Wilson's disease. N Engl J Med 1975;293:1300-1302.
16. Shimizu N, Yamaguchi Y, Aoki T: Treatment and management of Wilson's disease. Pediatr Int 1999;41:419-422.
17. Brewer GJ: Zinc acetate for the treatment of Wilson's disease. Expert Opin Pharmacother 2001;2:1473-1477.
18. Schilsky ML: Treatment of Wilson's disease: What are the relative roles of penicillamine, trientine, and zinc supplementation? Curr Gastroenterol 2001;3:54-59.
19. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V, Dick RD, Wang Y: Treatment of Wilson's disease with zinc. 12. Interaction with other anti-copper agents. J Am Coll Nutr 1993;12:26-30.